Shares of Vitamin Shoppe Inc (NYSE:VSI) reached a new 52-week high on Friday . The stock traded as high as $11.80 and last traded at $11.75, with a volume of 43199 shares changing hands. The stock had previously closed at $10.85.

Several research firms have recently weighed in on VSI. ValuEngine upgraded shares of Vitamin Shoppe from a “hold” rating to a “buy” rating in a research report on Wednesday. Zacks Investment Research upgraded shares of Vitamin Shoppe from a “sell” rating to a “hold” rating in a research report on Wednesday, August 1st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $3.92.

The stock has a market capitalization of $263.38 million, a P/E ratio of 52.14 and a beta of 0.57. The company has a current ratio of 1.96, a quick ratio of 0.44 and a debt-to-equity ratio of 0.32.

Vitamin Shoppe (NYSE:VSI) last issued its earnings results on Wednesday, August 8th. The specialty retailer reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.27. The company had revenue of $293.10 million for the quarter, compared to analysts’ expectations of $279.87 million. Vitamin Shoppe had a negative net margin of 8.76% and a positive return on equity of 2.42%. analysts expect that Vitamin Shoppe Inc will post 0.12 earnings per share for the current year.

In other Vitamin Shoppe news, Chairman Alex Smith bought 12,666 shares of the firm’s stock in a transaction that occurred on Tuesday, May 29th. The shares were bought at an average price of $5.24 per share, for a total transaction of $66,369.84. Following the transaction, the chairman now directly owns 19,118 shares in the company, valued at $100,178.32. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Guillermo Marmol bought 20,000 shares of the firm’s stock in a transaction that occurred on Friday, May 25th. The stock was acquired at an average price of $5.15 per share, for a total transaction of $103,000.00. Following the transaction, the director now owns 29,631 shares in the company, valued at $152,599.65. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 33,911 shares of company stock worth $175,906. 18.50% of the stock is owned by corporate insiders.

Large investors have recently modified their holdings of the stock. California Public Employees Retirement System grew its holdings in Vitamin Shoppe by 5.0% in the 1st quarter. California Public Employees Retirement System now owns 282,758 shares of the specialty retailer’s stock worth $1,230,000 after acquiring an additional 13,338 shares during the last quarter. Trexquant Investment LP bought a new stake in Vitamin Shoppe in the 2nd quarter worth $105,000. Nisa Investment Advisors LLC bought a new stake in Vitamin Shoppe in the 2nd quarter worth $129,000. GSA Capital Partners LLP bought a new stake in Vitamin Shoppe in the 1st quarter worth $109,000. Finally, Teton Advisors Inc. grew its holdings in Vitamin Shoppe by 83.3% in the 2nd quarter. Teton Advisors Inc. now owns 55,000 shares of the specialty retailer’s stock worth $382,000 after acquiring an additional 25,000 shares during the last quarter. Institutional investors own 88.62% of the company’s stock.

About Vitamin Shoppe

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Read More: Book Value Of Equity Per Share – BVPS Explained

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.